A federal court filing says both Ole Miss students had the same three compounds found in pills recovered in their rooms, tightening the focus on a single product line tied to each scene.
Story Highlights
- Court documents report the same three compounds in both students’ toxicology results.
- The compounds reportedly match those found in Smax Mango Breeze pills recovered near both scenes.
- Investigators documented matching or similar Smax-branded packaging from both locations.
- Officials earlier warned about kratom-like products while formal causes of death remained pending.
Federal filing links shared compounds to recovered pills
Federal court documents cited by reporters state that toxicology for Aiden Hamilton and Robert Strang showed mitragynine, MGM-15, and MGPI in both students’ systems. The filing also links those same compounds to Smax Mango Breeze pills found in each student’s room. This alignment points to a possible shared exposure from the same product line, according to the reporting that summarized the filing’s contents.
Investigators and prosecutors are pursuing a related retail source angle. Reporting describes seized items tied to local stores and highlights how the compounds named in toxicology mirror the substances identified in recovered pills. While this suggests a common thread, officials have not publicly released the full laboratory reports, so exact concentrations and testing methods are not in the public record yet.
Packaging similarities bolster the product trail
Evidence logs described in news accounts say officers recovered Smax or Smax Pseudo-DHM packaging during both investigations. Outlets reported identical or materially similar packaging details, including listed ingredients and a $39.99 price on related inventory. These packaging links, together with the named compounds, support investigators’ focus on specific Smax-branded products as a shared source of exposure across both scenes, as summarized by the coverage of court filings and searches.
Local narcotics officials previously said packaged kratom sold from a retail store was found during each death investigation. Their public statements urged caution around kratom-like products while also noting that no specific substance had been confirmed as the cause of either death at that time. That earlier guidance aligns with the product-recovery details now described in the charging and search materials.
Cause of death remains distinct from detection
Completed toxicology can identify what was present, but it does not by itself decide why someone died. Medical examiners consider scene details, medical history, autopsy findings, and drug levels when they determine a cause. Forensic guidance underscores that detection is not the same as causation, and that interpretation depends on context and concentrations, which are not yet public in this case.
News reports stressed that authorities had not officially tied a single substance to either death, even as attention centered on kratom-like products. Reviews of kratom cases show that deaths are rare and often involve other drugs, which is why concentration data and full autopsy results matter. The Food and Drug Administration notes that the role of kratom in reported deaths is often unclear due to polysubstance use.
Why this matters to families and communities
College towns want clear answers fast, but the justice process can move slowly. Families deserve to know what happened, and students need straightforward safety guidance. The current record shows a strong product trail, shared analytes, and overlapping packaging. It also shows caution from officials about naming a cause of death before all findings are final. That tension can frustrate the public, but it reflects how forensic work establishes facts step by step.
Toxicology reports reveal same controlled substances in 2 Ole Miss students found dead: court docshttps://t.co/RgkSAKclId
— BREAKING NEWZ Alert (@MustReadNewz) October 11, 2026
Regulators and lawmakers also face pressure. When a product sold over the counter is linked to two deaths in one community, people expect swift action. At the same time, durable policy should rest on complete lab data, clear product identification, and sound evidence rules. That balance—speed with rigor—is how institutions earn trust while protecting public health and due process.
Sources:
foxnews.com, wbtv.com, whmi.com, clarionledger.com, apnews.com, newsweek.com
